Option chain shows key data for BioSig Technologies's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for BioSig Technologies.

BioSig Technologies (NASDAQ:BSGM) Stock, Option Chain

BioSig Technologies

BioSig Technologies Inc is a commercial-stage medical device company with an advanced digital signal processing technology platform to deliver insights to the treatment of cardiovascular arrhythmias. Through collaboration with physicians, experts, and healthcare leaders across the field of electrophysiology (EP), It is committed to addressing healthcare's biggest priorities saving time, saving costs, and saving lives. Its first product, the PURE EP System, is an FDA-cleared non-invasive class II device consisting of a unique combination of hardware and software designed to provide unprecedented signal clarity and precision for real-time visualization of intracardiac signals paving the way for personalized patient care.

News

BSGM

BioSig Technologies shares are trading lower by 67% during Tuesday&#39;s session. The company said it was notified by the Nasdaq Hearings Panel that its common stock will be delisted.

Why BioSig Technologies (BSGM) Shares Are Down Over 60%

BioSig Technologies shares are trading lower by 18% during Thursday&#39;s session. The company announced a $3 million registered direct offering.

Why BioSig Technologies (BSGM) Shares Are Falling

analysis-4937349

Pre-Market Outlook

Markets

Movers

Trading Ideas

ADXN

BLND

CHGG

COUR

CSLR

CYCC

GWAV

ICLK

ILAG

LICN

LOGI

MOVE

MRIN

SGBX

WRNT

ZAPP

Why GeneDx Shares Are Trading Higher By 37%; Here Are 20 Stocks Moving Premarket

BioSig Technologies Inc

Management

Press Releases

BioSig Technologies, Inc. Appoints Mr. Anthony Amato to Position of Chief Executive Officer, Effective Immediately

BioSig Technologies, Inc. Announces New Appointments to its Now Fully Constituted Board of Directors, which is Comprised of 5 Board Members, 3 Independent

BioSig Technologies Chief Executive Officer Mr. Anthony Amato Issues the Following Letter to Shareholders

Financing

BioSig Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

BioSig Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

BioSig Technologies Appoints Mr. Ferdinand Groenewald to Position of Interim Chief Financial Officer and Principal Accounting Officer

BioSig Technologies Improves Balance Sheet, Announces Reduction in Outstanding Payables during Q2 2024

BioSig Technologies Announces Intent to Acquire the Assets of Neuro-Kinesis Corporation

BioSig Technologies' Common Stock to Resume Trading on the NASDAQ Exchange, Wednesday, October 23, 2024 After Its Successful Appeal to the NASDAQ Panel

BioSig Regains Compliance with Nasdaq's Minimum Bid Price Requirement

Adagio Medical Holdings, Inc - Common Stock

Adagio Medical Holdings

Aethlon Medical

Accelerate Diagnostics, Inc. - Common Stock

Accelerate Diagnostics

Biomerica

Envoy Medical, Inc. - Class A Common Stock

Envoy Medical

Co-Diagnostics

DIH Holding US, Inc. - Class A Common Stock

DIH Holding US

Daxor

Ekso Bionics Holdings, Inc. - Common Stock

Ekso Bionics Holdings

Femasys

SeaStar Medical Holding Corporation - Common Stock

SeaStar Medical Holding

Intelligent Bio Solutions Inc. - Common Stock

Intelligent Bio Solutions

Iridex

Modular Medical

NeuroOne Medical Technologies Corporation - Common Stock

NeuroOne Medical Tech

Neuraxis

NeuroMetrix

Nexalin Technology

PAVmed

Predictive Oncology

Precision Optics Corporation, Inc. - Common stock

Precision Optics Corp

Strata Skin Sciences, Inc. - Common Stock

Strata Skin Sciences

Trinity Biotech plc - American Depositary Shares

Trinity Biotech

Beyond Air

Xylo Technologies Ltd. - American Depositary Shares

Xylo Technologies

Ascendiant Capital

Comments

BioSig Technologies

BioSig Technologies (BSGM) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga